Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about STAT6: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Comprehensive coverage of STAT6 in cytokine signaling, immune function, neuroinflammation, and implications for Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
| Gene Symbol | STAT6 |
| Full Name | Signal Transducer and Activator of Transcription 6 |
| Chromosome | 12q13.3 |
| Protein Type | Transcription Factor |
| Function | is a transcription factor activated specifically by interleukin-4 (IL-4) and interleukin-13 (IL-13) receptor signaling. |
| Amino Acids | 847 aa |
| Gene Type | Protein coding |
| Pathways | Akt, Apoptosis, Blood-Brain Barrier, Differentiation, Dna Repair |
| UniProt ID | P42262 |
| NCBI Gene ID | 6778 |
| Ensembl ID | ENSG00000141510 |
| OMIM | 601512 |
| GeneCards | STAT6 |
| Human Protein Atlas | STAT6 |
| Associated Diseases | ALS, Asthma, Inflammation, Neuroinflammation |
| Known Drugs/Compounds | BENVITIMOD, curcumin, Curcumin |
| Interactions | ARNT, JUN, HDAC5, OCLN, AHR, CLDN1 |
| KG Connections | 321 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
STAT6["STAT6"]
STAT6 -->|"inhibits"| Als["Als"]
STAT6 -->|"activates"| Cancer["Cancer"]
STAT6 -->|"activates"| Carcinoma["Carcinoma"]
STAT6 -->|"activates"| Tumor["Tumor"]
STAT6 -->|"expressed in"| Ms["Ms"]
STAT6 -->|"activates"| Neuroinflammation["Neuroinflammation"]
STAT6 -->|"activates"| Inflammation["Inflammation"]
BENVITIMOD["BENVITIMOD"] -->|"inhibits"| STAT6
HDAC5["HDAC5"] -->|"regulates"| STAT6
CLDN1["CLDN1"] -->|"inhibits"| STAT6
NRF2["NRF2"] -->|"inhibits"| STAT6
ARNT["ARNT"] -->|"activates"| STAT6
AHR["AHR"] -->|"activates"| STAT6
OCLN["OCLN"] -->|"inhibits"| STAT6
SLC7A11["SLC7A11"] -->|"activates"| STAT6
CLDN4["CLDN4"] -->|"inhibits"| STAT6| Target | Relation | Type | Str |
|---|---|---|---|
| SLC7A11 | upregulates | gene | 0.95 |
| DNA repair | promotes | process | 0.92 |
| homologous recombination | activates | pathway | 0.88 |
| Inflammation | activates | disease | 0.85 |
| Carcinoma | activates | disease | 0.75 |
| Tumor | activates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Nf-Κb | activates | pathway | 0.70 |
| Addiction | therapeutic_target | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Neuroinflammation | expressed_in | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Als | contributes_to | disease | 0.65 |
| Ms | contributes_to | disease | 0.65 |
| Inflammation | contributes_to | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Anxiety | therapeutic_target | disease | 0.65 |
| Stroke | therapeutic_target | disease | 0.65 |
| Epilepsy | therapeutic_target | disease | 0.65 |
| Depression | therapeutic_target | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Glioblastoma | activates | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Neuroinflammation | implicated_in | disease | 0.65 |
| Stroke | protects_against | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Inflammation | expressed_in | disease | 0.65 |
| Asthma | causes | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Inflammation | causes | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Senescence | protects_against | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| SLC7A11 | activates | gene | 0.64 |
| ARNT | activates | gene | 0.60 |
| JAK1 | expressed_in | gene | 0.60 |
| OVERVIEW | therapeutic_target | gene | 0.60 |
| STAT3 | expressed_in | gene | 0.60 |
| JAK1 | biomarker_for | gene | 0.60 |
| EPHA4 | expressed_in | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| HDAC5 | associated_with | gene | 0.90 |
| Curcumin | activates | drug | 0.85 |
| AKT | activates | gene | 0.70 |
| P38 | activates | gene | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| NF-ΚB | activates | gene | 0.70 |
| BENVITIMOD | inhibits | drug | 0.64 |
| HDAC5 | regulates | protein | 0.64 |
| CLDN1 | inhibits | gene | 0.60 |
| NRF2 | inhibits | gene | 0.60 |
| ARNT | activates | gene | 0.60 |
| AHR | activates | gene | 0.60 |
| OCLN | inhibits | gene | 0.60 |
| SLC7A11 | activates | gene | 0.60 |
| HDAC5 | activates | gene | 0.60 |
| JAK3 | expressed_in | gene | 0.60 |
| GAIN | expressed_in | gene | 0.60 |
| STAT1 | expressed_in | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| NPY1R | associated_with | gene | 0.60 |
| NPY | associated_with | gene | 0.60 |
| BDNF | contributes_to | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| DVL2 | therapeutic_target | gene | 0.60 |
| VEGF | associated_with | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| NQO1 | associated_with | gene | 0.60 |
| SOD1 | associated_with | gene | 0.60 |
| SIRT1 | therapeutic_target | gene | 0.60 |
| TAU | associated_with | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| ACSL4 | associated_with | gene | 0.60 |
| FOXP3 | inhibits | gene | 0.60 |
| MCC | associated_with | gene | 0.60 |
| SLC7A11 | associated_with | gene | 0.60 |
| GBM | activates | gene | 0.60 |
| TRIM28 | activates | gene | 0.60 |
| JAK1 | biomarker_for | gene | 0.60 |
| MERTK | expressed_in | gene | 0.60 |
| S100A9 | regulates | gene | 0.60 |
| ATG5 | activates | gene | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| SOCS1 | activates | gene | 0.60 |
| CEBPB | activates | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| JAK1 | activates | gene | 0.60 |
| BCL2L12 | activates | gene | 0.60 |
| BCL2 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||